Marvell Stock Jumps After Investor Day: Can MRVL Really Reach $70-90 Billion in Revenue?

Aadi Bihani Image

Aadi Bihani

Last updated:
11 min read
Why Is Marvell Stock Rising After Its Investor Day?
Table Of Contents
  • Why Marvell Stock Jumped After Investor Day
  • Why Marvell Gave Back Part of Its Rally
  • Marvell's AI Opportunity Goes Beyond Custom Processors
  • Can Marvell Turn Revenue Growth Into Shareholder Earnings?
  • MRVL Stock Valuation: What Different Earnings Outcomes Could Mean
  • The Risks That Could Undermine Marvell's Forecast
  • What Investors Should Watch After Marvell's Rally
  • Author’s View on Marvell Stock After Investor Day

Marvell gave investors a striking glimpse of its possible future: a company generating as much as $90 billion in annual revenue, compared with about $8.2 billion in FY2026. 

MRVL shares jumped more than 11% during October 6 trading before finishing 5.81% higher. That retreat captures the question facing investors: how much should they pay today for a business that could look dramatically different in four years?

Let's break down what Marvell changed, why MRVL stock rallied and then cooled, and whether its earnings outlook supports the excitement. We will also test what happens when the business grows but the stock's valuation becomes less generous.

Why Marvell Stock Jumped After Investor Day

The trigger was Marvell's October 6 Investor Day, where management raised its FY2028 revenue outlook and introduced a much larger FY2031 ambition. This was a strategy and financial-outlook update, rather than a new quarterly earnings release.

ForecastPrevious outlookOctober 6 update
FY2028 total revenueAbout $18 billionAbout $20 billion
FY2029 custom revenueMore than $10 billionMore than $12 billion
FY2031 total revenueNo comparable company target previously disclosed$70 billion to $90 billion

Source: Marvell Investor Day 2026; Reuters, October 6, 2026.

The nearer-term change adds $2 billion, or 11.1%, to the FY2028 forecast. Against management's roughly $12 billion FY2027 outlook, $20 billion implies approximately 66.7% annual growth. Marvell's fiscal years run ahead of the calendar: FY2028 ends around January 2028, while FY2031 broadly captures calendar 2030 and ends around January 2031.

The bigger surprise was the distance between management and Wall Street. Reuters reported a pre-event FY2031 revenue estimate of $46.85 billion from four analysts polled by Visible Alpha. Marvell's $80 billion midpoint sits about 70.8% above that figure. This was a small long-range analyst sample, so it should not be treated as the view of every analyst covering MRVL.

I think the event gave investors grounds to reconsider the scale and duration of Marvell's earnings growth. A forecast that changes the possible size of a business can matter much more than a small quarterly earnings beat.

Why Marvell Gave Back Part of Its Rally

The session's numbers show both enthusiasm and resistance.

Marvell October 6, 2026 price measureValue
Previous close$271.25
Intraday high$301.27
Gain at the intraday high11.07%
Closing price$287.01
Closing gain5.81%
Decline from intraday high to close4.73%
Share of peak dollar gain surrendered47.5%

Source: Investing.com historical prices; calculations using October 5 and October 6 closes.

The final figure needs careful interpretation. Marvell surrendered $14.26 of its $30.02 peak gain above the previous close. It did not fall 47.5% from its peak price. Trading volume was approximately 51.29 million shares, almost four times the preceding session's 12.90 million, indicating substantial participation.

Price data cannot identify exactly who traded or why. Profit-taking after a sharp advance, disagreement over the value of distant forecasts, and event-related trading are plausible explanations for the retreat; none can be established as the sole cause from the daily chart.

Valuation provides a credible context. Barron's reported that MRVL traded at about 50 times projected earnings over the following 12 months after the event, before subsequent estimate revisions. A large amount of anticipated growth was therefore already reflected in the price.

Our reading of the session is cautiously positive. Investors accepted a meaningful upward reset, while prices above $300 attracted enough opposing orders to prevent the stock from finishing near its high. That makes $301.27 a useful future reference point, but one session cannot establish a durable technical ceiling.

Marvell's AI Opportunity Goes Beyond Custom Processors

Marvell develops custom silicon and the technology that connects processors, memory, storage and servers. Its investment case increasingly depends on how efficiently AI systems move data, alongside how much computing power they contain.

An application-specific integrated circuit, or ASIC, is a chip designed for a particular job. Marvell helps cloud companies develop these specialised chips. Its interconnect products enable high-speed data transfer, including through optical links that use light.

Think of an AI data centre as a huge restaurant kitchen. The processors are the chefs; the connections carry ingredients between stations. Adding hundreds of brilliant chefs achieves little if the corridors are jammed. Marvell supplies technology that helps keep those corridors moving.

Management's FY2031 revenue breakdown makes that distinction financially meaningful.

BusinessFY2031 revenue at management's midpointShare of $80 billion total
InterconnectAbout $37.5 billion46.9%
Custom siliconAbout $30 billion37.5%
Switching and storageAbout $10 billion12.5%
Communications and otherAbout $2.5 billion3.1%

Source: Marvell Investor Day presentation, slide 40; percentages calculated from its $80 billion midpoint.

Almost half the midpoint comes from interconnect. Reducing the thesis to whether Marvell can win another flagship AI processor contract misses its largest projected revenue contributor.

Another opportunity is “XPU attach”: supporting chips around an AI processor, such as networking, memory-interface and storage components. Winning more of those positions can broaden Marvell's revenue within a customer's system. Management attributed much of the FY2029 custom forecast increase to this opportunity.

Our strongest positive view is that Marvell has several ways to participate in expanding AI infrastructure. However, product diversity does not eliminate dependence on the same large cloud customers and their spending budgets. Several revenue streams can still slow together.

Can Marvell Turn Revenue Growth Into Shareholder Earnings?

Revenue is only the beginning. The investment outcome depends on the profit Marvell retains, the cash it generates and how much earnings belongs to each share. Free cash flow is the cash left after operating needs and capital spending.

FY2031 financial measureManagement's long-term adjusted target
Gross margin56% to 59%
Operating margin44% to 46%
Tax rate15%
Free cash flow as a percentage of revenueAbove 36%
Earnings per share at the revenue midpointAbove $30

Source: Marvell Investor Day presentation, slide 142; Investor Day management transcript.

Gross margin measures revenue left after product costs. Operating margin also accounts for expenses such as research and administration. Custom processors can carry lower gross margins, yet still generate attractive operating profits when customers fund development work and production reaches scale.

The important analytical point is that a lower gross margin need not mean weaker earnings. Investors should examine the product mix and operating expenses together, rather than treating every decline in gross margin as deterioration.

At $80 billion of revenue, a 45% operating margin would produce $36 billion of adjusted operating profit. Each percentage point of operating margin would be worth $800 million. Small differences in execution become enormous at that scale.

There is also a demanding growth requirement hidden inside the headline. Moving from $20 billion in FY2028 to the $80 billion FY2031 midpoint requires revenue to quadruple in three fiscal years, equivalent to about 58.7% annual growth.

That is why we would treat the long-range target as an ambitious destination, with intermediate results doing the work of establishing credibility. The stock deserves greater confidence as Marvell demonstrates profitable production ramps, rather than merely repeating its endpoint.

MRVL Stock Valuation: What Different Earnings Outcomes Could Mean

A useful way to evaluate MRVL is to vary both its eventual earnings and the valuation investors assign to them.

Illustrative future share price = annual earnings per share × P/E multiple

The following sensitivity analysis starts from $287.01 and uses approximately 4.3 years to the end of FY2031. The EPS outcomes are illustrative assumptions, not our forecasts. The $30 row uses a round-number approximation of management’s above-$30 adjusted target; the 20 and 25 multiples are deliberately lower valuation assumptions, not predictions.

Illustrative FY2031 outcomeAdjusted EPS assumedP/E assumedImplied future priceTotal price changeAnnualised price return
Substantial execution shortfall$1220$240-16.4%-4.1%
Growth falls well short of target$1520$3004.5%1.0%
Strong growth with some target shortfall$2225$55091.6%16.3%
Around management's EPS target$3025$750161.3%25.0%

Source: Author calculations. These are conditional sensitivities, without assigned probabilities; they exclude dividends, taxes, fees and currency movements.

The second row is the lesson investors should remember. Marvell could produce $15 of adjusted EPS, far above FY2026's actual $2.84, and still deliver only about 1% annual price appreciation if its eventual P/E fell to 20.

Business growth alone does not guarantee an attractive stock return. The starting price and ending valuation both matter.

We can also reverse the calculation. Assume an investor wants 12% annual price appreciation, at a future P/E of 25:

Required future price = $287.01 × 1.12^4.3 = approximately $467.23

Required FY2031 adjusted EPS = $467.23 ÷ 25 = approximately $18.69

That earnings hurdle sits meaningfully below management's above-$30 target. It explains why Marvell's outlook can support a compelling long-term case even after allowing for some disappointment.

But the cushion is conditional. A lower eventual P/E, delayed earnings, weaker cash conversion or greater dilution would change the result. This calculation is a way to test assumptions, rather than a present-day fair-value estimate.

The Risks That Could Undermine Marvell's Forecast

The most consequential risk is execution at exceptional scale. A design win means a customer has selected a chip for a programme; revenue still depends on successful development and production. A promising project can move more slowly than expected without disappearing entirely.

Marvell's filings also identify dependence on a few customers, advanced semiconductor supply, and the possibility of customers developing their own solutions or choosing competitors. These are connected risks: strong demand has limited value if the required manufacturing capacity or customer deployment is delayed.

The Google relationship deserves particular precision. Marvell's August 19 filing disclosed a warrant covering about 58.97 million shares at $206.58 each. Most of its vesting depends on discretionary purchases in 240 tranches of $500 million.

Multiplying those tranches produces the widely discussed $120 billion purchasing threshold. It is a condition for full purchase-linked vesting, not a guaranteed revenue backlog or a fixed payment owed to Marvell.

The arrangement offers substantial commercial potential but also makes per-share economics important. If vested warrants are exercised for newly issued shares, dilution must be assessed alongside the proceeds Marvell receives. Investors should not simply subtract the full warrant share count from management's EPS target without understanding the share assumptions already embedded in that target.

Adjusted earnings need scrutiny too. In Q2 FY2027, reported GAAP EPS was $0.33, compared with adjusted EPS of $0.94. Operating cash flow was $605.5 million, while adjusted net income was $865.9 million. The quarter also included $326.2 million of stock-based compensation.

Those differences do not invalidate adjusted earnings. Acquisition accounting, equity compensation and cash timing explain why measures differ. But they do mean the eventual above-$30 adjusted EPS target should be evaluated alongside reported earnings, cash generation and diluted shares.

Our preferred measure of success is expanding cash generation per share. Revenue growth accompanied by rising dilution and persistent adjustments deserves a less generous valuation than equally fast growth with strong cash conversion.

What Investors Should Watch After Marvell's Rally

The next stage is to connect the long-term forecast to evidence that arrives quarter by quarter.

What to trackWhy it matters
Q3 FY2027 revenue against the $3.15 billion guidance midpoint, with a 5% tolerance either wayTests the immediate production ramp
FY2028 progress toward approximately $20 billionTests the nearer-term forecast upgrade
Interconnect growth and new optical deploymentsTests the largest projected FY2031 contributor
Operating margin and free cash flowTests whether revenue creates durable profit and cash
Diluted shares and customer purchase-linked warrantsTests how much growth reaches each share

Source: Marvell Q2 FY2027 earnings guidance and Investor Day outlook; author assessment.

Analysts have begun adjusting their expectations, but their targets remain widely separated.

AnalystFirmUpdated targetPrice change from $287.01
David O'ConnorPiper Sandler$40039.4%
Tore SvanbergStifel$37028.9%
Timothy ArcuriUBS$35021.9%
Joseph MooreMorgan Stanley$3004.5%
Aaron RakersWells Fargo$36527.2%

Source: Stock Analysis, using TipRanks analyst data dated October 7, 2026; percentage changes calculated from the October 6 close.

These selected targets are analyst opinions, not guaranteed outcomes or a comprehensive consensus. Their spread is useful because it shows how differently professionals value the same opportunity.

Our earlier Marvell Q2 earnings analysis explains the expectations Marvell faced before this event. The comparison matters: October's update provides a larger growth framework, but the test remains whether results keep pace with the expectations embedded in the share price.

Author’s View on Marvell Stock After Investor Day

Marvell now has a stronger investment case than a generic claim that AI spending will keep rising. Its projected business mix, supporting-chip opportunities and financial targets provide specific drivers that investors can test.

We see substantial long-term potential if connectivity growth and custom production translate into the earnings management envisages. The scenario analysis shows that MRVL does not necessarily need to reach every headline target to generate attractive returns under a moderate future valuation.

However, $287.01 still asks investors to trust an extraordinary expansion. The intraday retreat is a reminder that an exciting forecast can meet resistance when its price assumes considerable success.

For anyone assessing Marvell stock, the decisive question is how much future earnings they believe will arrive, how quickly, and at what valuation. We would attach more weight to interconnect revenue, operating profit and cash per share than to another increase in the size of the AI market.

Share: